Vivani Medical: Q1 Earnings Snapshot
ALAMEDA, Calif. (AP) — ALAMEDA, Calif. (AP) — Vivani Medical, Inc. (VANI) on Tuesday reported a loss of $6.3 million in its first quarter.
The Alameda, California-based company said it had a loss of 11 cents per share.
_____
May 13, 2025
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
30 minutes ago
- Bloomberg
Disney to Pay Comcast $439 Million More for Its Hulu Stake
Walt Disney Co. must pay $438.7 million more to Comcast Corp. to complete its purchase of the Hulu streaming service, according to an appraisal process conducted by investment bankers. The transaction will close before July 24, Disney said in a regulatory filing Monday.
Yahoo
31 minutes ago
- Yahoo
Cohen & Steers Announces Preliminary Assets Under Management and Net Flows for May 2025
NEW YORK, June 9, 2025 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $88.6 billion as of May 31, 2025, an increase of $1.1 billion from assets under management of $87.5 billion at April 30, 2025. The increase was due to market appreciation of $1.3 billion, partially offset by distributions of $150 million and net outflows of $88 million. Assets Under Management (unaudited) ($ in millions) AUM Net MarketAUM By investment vehicle: 4/30/2025 Flows App/(Dep) Distributions 5/31/2025 Institutional Accounts: Advisory $19,937 $10 $352 - $20,299 Subadvisory 14,091 (19) 306 (57) 14,321 Total Institutional Accounts 34,028 (9) 658 (57) 34,620 Open-end Funds 42,210 (80) 510 (42) 42,598 Closed-end Funds 11,271 1 176 (51) 11,397 Total AUM $87,509 ($88) $1,344 ($150) $88,615 About Cohen & Steers. Cohen & Steers is a leading global investment manager specializing in real assets and alternative income, including listed and private real estate, preferred securities, infrastructure, resource equities, commodities, as well as multi-strategy solutions. Founded in 1986, the firm is headquartered in New York City, with offices in London, Dublin, Hong Kong, Tokyo and Singapore. View original content: SOURCE Cohen & Steers, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
32 minutes ago
- Yahoo
Calavo (NASDAQ:CVGW) Reports Sales Below Analyst Estimates In Q1 Earnings, Stock Drops 15.3%
Fresh produce company Calavo Growers (NASDAQ:CVGW) fell short of the market's revenue expectations in Q1 CY2025 as sales rose 3.3% year on year to $190.5 million. Its non-GAAP profit of $0.40 per share was 25% below analysts' consensus estimates. Is now the time to buy Calavo? Find out in our full research report. Revenue: $190.5 million vs analyst estimates of $192.8 million (3.3% year-on-year growth, 1.1% miss) Adjusted EPS: $0.40 vs analyst expectations of $0.53 (25% miss) Adjusted EBITDA: $11.4 million vs analyst estimates of $14.74 million (6% margin, 22.7% miss) Operating Margin: 4%, in line with the same quarter last year Market Capitalization: $493.7 million 'Our second fiscal quarter performance reflects the strength of our commercial strategy and disciplined operational execution amid continued volatility in the avocado market. Revenue grew year-over-year, driven by strong pricing performance,' said Lee Cole, President and Chief Executive Officer of Calavo Growers, Inc. A trailblazer in the avocado industry, Calavo Growers (NASDAQ:CVGW) is a pioneering California-based provider of high-quality avocados and other fresh food products. A company's long-term performance is an indicator of its overall quality. Even a bad business can shine for one or two quarters, but a top-tier one grows for years. With $694.5 million in revenue over the past 12 months, Calavo is a small consumer staples company, which sometimes brings disadvantages compared to larger competitors benefiting from economies of scale and negotiating leverage with retailers. As you can see below, Calavo's demand was weak over the last three years. Its sales fell by 15.8% annually, a tough starting point for our analysis. This quarter, Calavo's revenue grew by 3.3% year on year to $190.5 million, falling short of Wall Street's estimates. Looking ahead, sell-side analysts expect revenue to decline by 1.8% over the next 12 months. it's tough to feel optimistic about a company facing demand difficulties. Software is eating the world and there is virtually no industry left that has been untouched by it. That drives increasing demand for tools helping software developers do their jobs, whether it be monitoring critical cloud infrastructure, integrating audio and video functionality, or ensuring smooth content streaming. Click here to access a free report on our 3 favorite stocks to play this generational megatrend. If you've followed StockStory for a while, you know we emphasize free cash flow. Why, you ask? We believe that in the end, cash is king, and you can't use accounting profits to pay the bills. Calavo broke even from a free cash flow perspective over the last two years, giving the company limited opportunities to return capital to shareholders. We struggled to find many positives in these results as Calavo fell short of Wall Street's estimates across all key metrics. Overall, this quarter could have been better. The stock traded down 15.3% to $23.42 immediately after reporting. The latest quarter from Calavo's wasn't that good. One earnings report doesn't define a company's quality, though, so let's explore whether the stock is a buy at the current price. If you're making that decision, you should consider the bigger picture of valuation, business qualities, as well as the latest earnings. We cover that in our actionable full research report which you can read here, it's free. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
